Amalgation of Manathakkali karpam and Yoga therapy for Asthma

Phase 2

Not yet recruiting

• Conditions: Mild intermittent asthma, (2) ICD-10 Condition: J453||Mild persistent asthma,

• Registration Number: CTRI/2022/11/047594
• Lead Sponsor: Government siddha medical college

Brief Summary

This is a non randomised comparative open clinical trial to study the safety and efficacy of siddha trial drug Manathakkali karpam(internal) and siddhar yoga therapy. Siddhar yoga Therapy is given to 20 patients (group 1) for 48 days.For group 2 patients (20 in numbers) Internal medication Manathakkali karpam in a dosage of 30 to 60 ml twice daily along with siddhar yoga therapy is to be given for 48 days

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-11-21
• Study Start: 2022-11-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patience having anyone of the following symptoms Cough with or without expectoration Wheezing Dyspnoea.

Exclusion Criteria

Congestive cardiac failure Bronchiectasis Chronic bronchitis Status asthmaticus Pregnancy and lactating mother Any other serious systemic illnesses.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in symptoms of wheeze dyspnoea and chest tightness is assessed by	48 days
1. peak respiratory flow rate	48 days
2. low eosinophilic count	48 days
Comparing the clinical symptoms, corresponding radiological findings before and after treatment	48 days

Secondary Outcome Measures

Name	Time	Method
To study the time gap between the arisal of two asthma period	48 days

Trial Locations

Locations (1)

Government siddha medical college; 🇮🇳 Chennai, TAMIL NADU, India

Government siddha medical college

🇮🇳Chennai, TAMIL NADU, India

U Poorani

Principal investigator

7092120943

pooranikamala111@gmail.com